AdhexPharma is an independent French CDMO specializing in the development and manufacturing of transdermal patches, topical patches, and oral dissolving films. With over 40 years of experience, they produce 180 million units annually and have 15+ ongoing development projects. They are cGMP compliant with both EMA and FDA standards and recently acquired tesa Labtec GmbH to expand capabilities.
Transdermal delivery systems (TDS), Topical patches, Oral dissolving films (buccal, sublingual), Drug delivery development, Patch manufacturing
1 site worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.